Asprito 5 Tablet
By Asprito
Rx
15 Tablet in a Strip

Composition
Aripiprazole(5mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
August, 2025

liver
Asprito 5 Tablet is considered safe for use in patients with liver disease. The available data indicates that adjusting the dosage of Asprito 5 Tablet may not be necessary for these patients. It is always best to consult with your doctor before using this medication, especially if you have liver issues.

kidney
Asprito 5 Tablet is safe for patients with kidney disease. No dosage adjustment is necessary for Asprito 5 Tablet use in such cases.

alcohol
It is unsafe to consume alcohol with Asprito 5 Tablet.

driving
When taking Asprito 5 Tablet, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness or dizziness. Refrain from driving if you experience these symptoms.

pregnancy
Asprito 5 Tablet may not be safe during pregnancy. Animal studies have indicated potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Kindly consult your doctor.

breastfeeding
Caution Asprito 5 Tablet is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Dihydrocarbostyril Drivative |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹131.93
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024